Patent directory · USPTO A61K / A61P
Patents matching “Vertex Pharmaceuticals Incorporated”
980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11186566
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
granted -
US 11179367
Pharmaceutical compositions for treating cystic fibrosis
granted -
US 11179394
Method for treating cancer using a combination of Chk1 and ATR inhibitors
granted -
US 11155533
Crystalline forms and compositions of CFTR modulators
granted -
US 11147770
Pharmaceutical composition and administrations thereof
granted -
US 11124805
Methods, compositions and kits for increasing genome editing efficiency
granted -
US 11117900
Compounds useful as inhibitors of ATR kinase
granted -
US 11110108
Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors
granted -
US 11110086
Compounds useful as inhibitors of ATR kinase and combination therapies thereof
granted -
US 11084804
Modulators of ATP-binding cassette transporters
granted -
US 11066417
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
granted -
US 11059826
Pteridinone compounds and uses thereof
granted -
US 11052075
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof
granted -
US 11021465
DNA-PK inhibitors
granted -
US 11008305
DNA-PK inhibitors
granted -
US 10988477
GCN2 inhibitors and uses thereof
granted -
US 10987348
Modulators of ATP-binding cassette transporters
granted -
US 10980746
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
granted -
US 10975061
Modulators of ATP-binding cassette transporters
granted -
US 10973830
Substituted quinoxaline DNA-PK inhibitors
granted -
US 10961232
Substituted pyrazines as ATR kinase inhibitors
granted -
US 10913761
2,7-dibromospiro[fluorene-9,4′-piperidine] compounds
granted -
US 10906891
Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
granted -
US 10874673
Inhibitors of influenza viruses replication
granted